≡ Risteys
R8

Documentation Changelog GitHub Contact & Feedback

L01XX Other antineoplastic agents

PheWeb

RX_L01XX

No definition available.

Endpoint definition

↥
FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Medicine purchases: ATC L01XX

1459

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

1139

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

1139

diagram downward connector

Include endpoints None

1139

diagram downward connector
RX_L01XX

Extra metadata

First used in FinnGen datafreeze DF3

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 1139 537 602
Unadjusted prevalence (%) 0.32 0.27 0.38
Mean age at first event (years) 65.68 64.80 66.46

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.06 3.60 [1.87, 6.93] 1.3e-4 273
15 years 0.01 1.68 [0.94, 2.97] 7.8e-2 102
5 years 0.01 4.73 [3.29, 6.81] 6.6e-17 112
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: RX_L01XX – L01XX Other antineoplastic agents
GWS hits:

Survival analyses between endpoints

↥

Plot

before L01XX Other antineoplastic agents
after L01XX Other antineoplastic agents

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after L01XX Other antineoplastic agents

↥